Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.

In the majority of human malignancies, maintenance of telomeres is achieved by reactivation of telomerase, whereas a smaller fraction uses an alternative telomere lengthening (ALT) mechanism. Here, we used 16 non-small cell lung cancer (NSCLC) cell lines to investigate telomere stabilization mechanisms and their effect on tumor aggressiveness. Three of 16 NSCLC cell lines (VL-9, SK-LU-1, and VL-7) lacked telomerase activity, correlating with significantly reduced tumorigenicity in vitro and in vivo. Of the three telomerase-negative cell lines, only SK-LU-1 displayed characteristics of an ALT mechanism (i.e., highly heterogeneous telomeres and ALT-associated promyelocytic leukemia bodies). VL-9 cells gained telomerase during in vitro propagation, indicating incomplete immortalization in vivo. In contrast, NSCLC metastasis-derived VL-7 cells remained telomerase and ALT negative up to high passage numbers and following transplantation in severe combined immunodeficient mice. Telomeres of VL-7 cells were homogeneously short, and chromosomal instability (CIN) was comparable with most telomerase-positive cell lines. This indicates the presence of an efficient telomere stabilization mechanism different from telomerase and ALT in VL-7 cells. To test the effect of ectopic telomerase reverse transcriptase (hTERT) in these unique ALT- and telomerase-negative tumor backgrounds, hTERT was transfected into VL-7 cells. The activation of telomerase led to an excessively rapid gain of telomeric sequences resulting in very long ( approximately 14 kb), uniform telomeres. Additionally, hTERT expression induced a more aggressive growth behavior in vitro and in vivo without altering the level of CIN. These data provide further evidence for a direct oncogenic activity of hTERT not based on the inhibition of CIN.

[1]  M. Cerone,et al.  A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT , 2005, Oncogene.

[2]  U. Pastorino,et al.  Lack of Telomerase Activity in Lung Carcinoids Is Dependent on Human Telomerase Reverse Transcriptase Transcription and Alternative Splicing and Is Associated with Long Telomeres , 2005, Clinical Cancer Research.

[3]  J. Barrett,et al.  Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. , 2005, Cancer research.

[4]  L. Guarente,et al.  A novel telomere structure in a human alternative lengthening of telomeres cell line. , 2005, Cancer research.

[5]  R. Reddel,et al.  Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies. , 2005, Cancer research.

[6]  M. Ladanyi,et al.  Divergent patterns of telomere maintenance mechanisms among human sarcomas: Sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas , 2004, Genes, chromosomes & cancer.

[7]  E. Montgomery,et al.  Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically. , 2004, The American journal of pathology.

[8]  E. Brambilla,et al.  Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours , 2004, British Journal of Cancer.

[9]  K. Kikuchi,et al.  The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma , 2003, Cancer.

[10]  W. Berger,et al.  Detection and quantification of transcripts for the catalytic subunit TERT and the RNA component of telomerase in rat tissue. , 2003, Analytical biochemistry.

[11]  James M. Roberts,et al.  Telomerase modulates expression of growth-controlling genes and enhances cell proliferation , 2003, Nature Cell Biology.

[12]  M. Ladanyi,et al.  Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. , 2003, Cancer research.

[13]  R. Newbold The significance of telomerase activation and cellular immortalization in human cancer. , 2002, Mutagenesis.

[14]  G. Hannon,et al.  Transformation of normal human cells in the absence of telomerase activation. , 2002, Cancer cell.

[15]  Li Mao,et al.  hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  Robert A. Weinberg,et al.  Telomerase contributes to tumorigenesis by a telomere length-independent mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Marchetti,et al.  Prediction of Survival in Stage I Lung Carcinoma Patients by Telomerase Function Evaluation , 2002, Laboratory Investigation.

[18]  R. Schulte‐Hermann,et al.  Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. , 2002, Journal of cell science.

[19]  R. Reddel,et al.  Alternative lengthening of telomeres in mammalian cells , 2002, Oncogene.

[20]  M. Henriksson,et al.  Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1 , 2002, Oncogene.

[21]  T. Kameya,et al.  Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer. , 2001, Lung cancer.

[22]  A. Jauch,et al.  Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas , 2001, Oncogene.

[23]  R. Reddel,et al.  Coexistence of Alternative Lengthening of Telomeres and Telomerase in hTERT-Transfected GM847 Cells , 2001, Molecular and Cellular Biology.

[24]  M. Blasco,et al.  Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes , 2001, The EMBO journal.

[25]  Carol W. Greider,et al.  Two Survivor Pathways That Allow Growth in the Absence of Telomerase Are Generated by Distinct Telomere Recombination Events , 2001, Molecular and Cellular Biology.

[26]  R. Reddel,et al.  Telomere maintenance by recombination in human cells , 2000, Nature Genetics.

[27]  R. Reddel The role of senescence and immortalization in carcinogenesis. , 2000, Carcinogenesis.

[28]  T. Mohr,et al.  Evidence for a role of FGF‐2 and FGF receptors in the proliferation of non‐small cell lung cancer cells , 1999, International journal of cancer.

[29]  R. Reddel,et al.  Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. , 1999, Cancer research.

[30]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[31]  E. Blackburn,et al.  Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Regev,et al.  Telomeric repeats on small polydisperse circular DNA (spcDNA) and genomic instability , 1998, Oncogene.

[33]  V. Lundblad,et al.  The telomerase reverse transcriptase: components and regulation. , 1998, Genes & development.

[34]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[35]  M. Oshimura,et al.  A repressor function for telomerase activity in telomerase‐negative immortal cells , 1998, Molecular carcinogenesis.

[36]  T. Slaga,et al.  Telomerase and cell proliferation in mouse skin papillomas , 1997, Molecular carcinogenesis.

[37]  E. Dmitrovsky,et al.  High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. , 1997, Journal of the National Cancer Institute.

[38]  D. Bowtell,et al.  Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. , 1997, Human molecular genetics.

[39]  R. Reddel,et al.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines , 1997, Nature Medicine.

[40]  W. Berger,et al.  Expression of the multidrug resistance‐associated protein (MRP) and chemoresistance of human non‐small‐cell lung cancer cells , 1997 .

[41]  R. Weinberg,et al.  hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.

[42]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[43]  B. Gallie,et al.  Development of retinoblastoma in the absence of telomerase activity. , 1996, Journal of the National Cancer Institute.

[44]  S. Lavi,et al.  Induction of circles of heterogeneous sizes in carcinogen-treated cells: two-dimensional gel analysis of circular DNA molecules , 1996, Molecular and cellular biology.

[45]  H. Tanke,et al.  Heterogeneity in telomere length of human chromosomes. , 1996, Human molecular genetics.

[46]  R. Reddel,et al.  Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.

[47]  C. Seelos,et al.  Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. , 1995, Oncogene.

[48]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[49]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Shay,et al.  The two-stage mechanism controlling cellular senescence and immortalization , 1992, Experimental Gerontology.

[51]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[52]  N. Wald,et al.  Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme , 2003 .

[53]  J. Shay,et al.  Telomerase in cancer and aging. , 2002, Critical reviews in oncology/hematology.

[54]  M. White,et al.  Absence of cancer–associated changes in human fibroblasts immortalized with telomerase , 1999, Nature Genetics.

[55]  Gregg B. Morin,et al.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT , 1997, Nature Genetics.

[56]  S. Bacchetti Telomere maintenance in tumour cells. , 1996, Cancer surveys.